Skip to main content

Vascepa Disease Interactions

There are 2 disease interactions with Vascepa (icosapent).

Moderate

Icosapent (applies to Vascepa) atrial fibrillation/flutter

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Arrhythmias

Icosapent is associated with an increased risk of atrial fibrillation or atrial flutter requiring hospitalization. In a cardiovascular outcomes trial, the incidence of atrial fibrillation was greater in patients with history of atrial fibrillation or atrial flutter; caution is recommended in these patients.

Switch to professional interaction data

Moderate

Icosapent (applies to Vascepa) liver disease

Moderate Potential Hazard, Moderate plausibility.

In patients with liver dysfunction, ALT and AST levels should be monitored periodically during therapy with icosapent; caution is recommended in these patients.

Switch to professional interaction data

Vascepa drug interactions

There are 76 drug interactions with Vascepa (icosapent).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer